| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.04 |